Skip to main content
Livermore
Livermore
ZHEN

Alliancebernstein L.P.

SEC CIK
0001109448
Latest filing
Aug 14, 2026

FULC holding history

Fulcrum Therapeutics, Inc. in every 13F filed by Alliancebernstein L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FULC overviewAll 13F holders of FULCFull Q2 2026 holdings

Shares (Q2 2026)
83,370
Value
$639.4K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of FULC by Alliancebernstein L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202683,370$639.4K<0.1%+48,800+141.2%AddedHolders
Q1 202634,570$391.0K<0.1%+19,300+126.4%AddedHolders
Q4 202515,270$172.7K<0.1%−59,320−79.5%ReducedHolders
Q3 202574,590$686.2K<0.1%00.0%UnchangedHolders
Q2 202574,590$513.2K<0.1%+9,000+13.7%AddedHolders
Q1 202565,590$188.9K<0.1%00.0%UnchangedHolders
Q4 202465,590$308.3K<0.1%00.0%UnchangedHolders
Q3 202465,590$234.2K<0.1%−157,392−70.6%ReducedHolders
Q2 2024222,982$1.38M<0.1%+36,017+19.3%AddedHolders
Q1 2024186,965$1.76M<0.1%−52,493−21.9%ReducedHolders
Q4 2023239,458$1.62M<0.1%+5,920+2.5%AddedHolders
Q3 2023233,538$1.04M<0.1%+233,538NewHolders
Q2 20230$00.0%−55,900−100.0%Sold outHolders
Q1 202355,900$159.3K<0.1%+13,100+30.6%AddedHolders
Q4 202242,800$311.6K<0.1%+5,200+13.8%AddedHolders
Q3 202237,600$304.0K<0.1%+4,100+12.2%AddedHolders
Q2 202233,500$164.0K<0.1%+11,900+55.1%AddedHolders
Q1 202221,600$511.0K<0.1%00.0%UnchangedHolders
Q4 202121,600$382.0K<0.1%+5,000+30.1%AddedHolders
Q3 202116,600$468.0K<0.1%00.0%UnchangedHolders
Q2 202116,600$174.0K<0.1%+900+5.7%AddedHolders
Q1 202115,700$185.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.